Speaker Profile

___	__
	Biography Lois Donovan MD FRCPC, Clinical Professor, University of Calgary; Endocrinologist, Departments of Medicine and Obstetrics and Gynecology, Alberta Health Services, Calgary Zone; Medical Director of Diabetes in Pregnancy. Lois is a clinician who out of frustration for lack of evidence has also become a clinical researcher with a focus on diabetes in pregnancy and thyroid function and thyroid disease in pregnancy. Her research focuses on ways of improving pregnancy outcomes in women that have type 1 and type 2 diabetes and their children. Her research also focuses on determining the best diagnostic and treatment thresholds for gestational diabetes and thyroid function during pregnancy to ensure evidenced based clinical decision thresholds are used so that maternal and child health is optimized. She is also an avid Cross Country skier who is grateful for the invitation to come and be part of this meeting and enjoy some Cross Country skiing while she is here. Disclosure I have a relationship with a for-profit and/or a not-for-profit organization to disclose. Funded grants or clinical trials: MITY Trial - CIHR research funded RCT of Metformin in Type 2 Diabetes in Pregnancy. All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity: Co-author of Diabetes Canada 2018 Pregnancy Guideline I intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Lois Donovan MD FRCPC, Clinical Professor, University of Calgary; Endocrinologist, Departments of Medicine and Obstetrics and Gynecology, Alberta Health Services, Calgary Zone; Medical Director of Diabetes in Pregnancy. Lois is a clinician who out of frustration for lack of evidence has also become a clinical researcher with a focus on diabetes in pregnancy and thyroid function and thyroid disease in pregnancy. Her research focuses on ways of improving pregnancy outcomes in women that have type 1 and type 2 diabetes and their children. Her research also focuses on determining the best diagnostic and treatment thresholds for gestational diabetes and thyroid function during pregnancy to ensure evidenced based clinical decision thresholds are used so that maternal and child health is optimized. She is also an avid Cross Country skier who is grateful for the invitation to come and be part of this meeting and enjoy some Cross Country skiing while she is here.
Disclosure
I have a relationship with a for-profit and/or a not-for-profit organization to disclose. Funded grants or clinical trials: MITY Trial - CIHR research funded RCT of Metformin in Type 2 Diabetes in Pregnancy. All other investments or relationships that could be seen by a reasonable, well-informed participant as having the potential to influence the content of the educational activity: Co-author of Diabetes Canada 2018 Pregnancy Guideline I intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).